Obsidian Therapeutics, Inc. has recorded no insider trading activity within the previous ninety days. Consequently, there are no recent transactions to report regarding company leadership or major stakeholders. The firm's last earnings report occurred on August 12, 2026, showing a positive deviation from analyst expectations.